23.13

5.90% -1.45

After Hours: 23.15 0.02 +0.09%

Elanco Animal Health Inc (ELAN)

Overview News Price History Option Chain Financials Discussions Forecast

Elanco Animal Health Inc stock is traded at $23.13, with a volume of 5.43M. It is down -5.90% in the last 24 hours and down -12.39% over the past month. Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

Previous Close:

$24.58

Open:

$24.65

24h Volume:

5.43M

Relative Volume:

1.09

Market Cap:

$11.50B

Revenue:

$4.72B

Net Income/Loss:

$-232.00M

P/E Ratio:

-49.60

EPS:

-0.4663

Net Cash Flow:

$284.00M

1W Performance:

-3.54%

1M Performance:

-12.39%

6M Performance:

+17.95%

1Y Performance:

+113.97%

1-Day Range:

$22.74

$24.77

1-Week Range:

$22.74

$25.68

52-Week Range:

$8.02

$27.72

Elanco Animal Health Inc Stock (ELAN) Company Profile

Name

Elanco Animal Health Inc

Sector

Healthcare (1112)

Industry

Drug Manufacturers - Specialty & Generic (83)

Phone

877-352-6261

Address

450 ELANCO CIRCLE, INDIANAPOLIS

Employee

9,900

Twitter

@Elanco

Next Earnings Date

2026-02-24

Latest SEC Filings

ELAN's Discussions on Twitter

Compare ELAN vs TAK, ZTS, HLN, TEVA, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ELAN Elanco Animal Health Inc	23.13	12.22B	4.72B	-232.00M	284.00M	-0.4663
TAK Takeda Pharmaceutical Co Adr	17.91	57.06B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	113.35	49.23B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.80	43.52B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	28.74	34.68B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	522.83	23.34B	3.18B	1.33B	1.04B	27.90

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-22-26	Upgrade	Piper Sandler	Neutral → Overweight
Dec-09-25	Initiated	Barclays	Overweight
Nov-21-25	Initiated	KeyBanc Capital Markets	Overweight
Nov-19-25	Upgrade	Argus	Hold → Buy
Oct-07-25	Upgrade	JP Morgan	Neutral → Overweight
Jul-17-25	Upgrade	Leerink Partners	Market Perform → Outperform
Jun-26-25	Upgrade	William Blair	Mkt Perform → Outperform
Dec-09-24	Initiated	UBS	Buy
Dec-02-24	Initiated	Leerink Partners	Market Perform
Sep-19-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-05-24	Upgrade	Stifel	Hold → Buy
Dec-19-23	Initiated	Jefferies	Buy
Dec-15-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Dec-07-23	Initiated	Exane BNP Paribas	Outperform
Apr-20-23	Upgrade	Barclays	Equal Weight → Overweight
Aug-18-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-16-22	Downgrade	JP Morgan	Overweight → Neutral
Jul-21-22	Downgrade	Goldman	Buy → Sell
Jul-12-22	Initiated	Piper Sandler	Neutral
Nov-18-21	Initiated	Morgan Stanley	Overweight
Oct-28-21	Downgrade	Stifel	Buy → Hold
Aug-05-21	Resumed	Credit Suisse	Outperform
Jun-15-21	Upgrade	Cleveland Research	Underperform → Neutral
May-11-21	Upgrade	Barclays	Underweight → Equal Weight
May-11-21	Upgrade	Gabelli & Co	Hold → Buy
Apr-15-21	Initiated	Stifel	Buy
Mar-22-21	Downgrade	Gabelli & Co	Buy → Hold
Feb-26-21	Upgrade	Credit Suisse	Neutral → Outperform
Dec-09-20	Downgrade	Argus	Buy → Hold
Nov-09-20	Downgrade	Barclays	Overweight → Underweight
Aug-20-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Aug-13-20	Resumed	Credit Suisse	Neutral
Aug-04-20	Resumed	Goldman	Buy
Jul-27-20	Downgrade	Cleveland Research	Neutral → Underperform
Apr-02-20	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-10-20	Initiated	Raymond James	Mkt Perform
Dec-19-19	Upgrade	BofA/Merrill	Neutral → Buy
Nov-07-19	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-23-19	Initiated	Barclays	Overweight
Aug-26-19	Downgrade	BofA/Merrill	Buy → Neutral
Aug-15-19	Upgrade	UBS	Sell → Neutral
May-23-19	Initiated	Guggenheim	Neutral
Mar-18-19	Upgrade	BofA/Merrill	Neutral → Buy
Mar-13-19	Resumed	Morgan Stanley	Equal-Weight
Feb-12-19	Initiated	William Blair	Mkt Perform
Jan-23-19	Initiated	UBS	Sell
Jan-15-19	Initiated	Argus	Buy
Oct-15-18	Initiated	Morgan Stanley	Equal-Weight

View All

Elanco Animal Health Inc Stock (ELAN) Latest News

Mar 26, 2026

Elanco Beats Investor Suit Over Dog Drug's Reg Challenges - Law360

Mar 26, 2026

Elanco Animal Health Drops More Than 5% – What’s Behind the Abrupt Decline? - Bitget

Mar 26, 2026

Vanguard reports 0 shares of Elanco after realignment (NYSE: ELAN) - Stock Titan

Mar 26, 2026

Elanco Gets Investors’ Dog Itch Drug Development Suit Dismissed - Bloomberg Law News

Mar 26, 2026

Elanco (ELAN) Jumps 19.7% to Record High on Earnings Boost - msn.com

Mar 26, 2026

Mar 25, 2026

Syngulon announces licensing agreement with Elanco Animal Health - PRWeb

Mar 25, 2026

Mar 24, 2026

Elanco (ELAN) CEO receives deferred stock units in compensation grant - Stock Titan

Mar 24, 2026

Elanco (NYSE: ELAN) executive receives new deferred stock unit grant - Stock Titan

Mar 24, 2026

Elanco (ELAN) CFO receives 8.216 deferred stock units as compensation award - Stock Titan

Mar 24, 2026

Mar 23, 2026

Elanco Animal (ELAN) climbs 7.6% on upbeat outlook, sets sights on AI - MSN

Mar 23, 2026

ELAN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 23, 2026

Mar 22, 2026

Pricier vet care: Fewer visits but still many $11,000 surgeries - Fortune

Mar 22, 2026

Mar 21, 2026

New Mexico Educational Retirement Board Invests $2 Million in Elanco Animal Health Incorporated $ELAN - MarketBeat

Mar 21, 2026

Mar 20, 2026